A study of ultralow dose rituximab as adjuvant to standard of care in treatment of significant and extensive pemphigus vulgaris: A case series von Patel, Nayankumar H., Padhiyar, Jignaben K., Patel, Jahnvi R., Patel, Kathak A., Lakum, Megha P., Oza, Yaksh Pradeep, Patel, Harisiddhi Bharatbhai, Chaudhary, Prashant Bhikhabhai

Volltext